Drug-Induced Erythema Multiforme

Peeyush Shivhare; Naqoosh Haidry; Anka Sharma; Deepali Agrawal; Abhishek Gupta; Shalini Subramanyam

doi:10.1155/2023/8706006

Drug-Induced Erythema Multiforme

Case Rep Dermatol Med. 2023 Oct 23:2023:8706006. doi: 10.1155/2023/8706006. eCollection 2023.

Authors

Peeyush Shivhare¹, Naqoosh Haidry¹, Anka Sharma², Deepali Agrawal³, Abhishek Gupta⁴, Shalini Subramanyam⁵

Affiliations

¹ Department of Dentistry, All India Institutes of Medical Sciences, Patna 801507, India.
² Department of Oral Medicine and Radiology, Dental Institute, Rajendra Institute of Medical Sciences, Ranchi 834009, India.
³ Oracle CBCT, Oral Medicine and Radiology, Faridabad 121003, India.
⁴ Department of Oral Medicine and Radiology, School of Dental Sciences, Chitwan Medical College, Bharatpur 44207, Chitwan, Nepal.
⁵ Private Dental Clinic, Bangalore 560038, India.

Abstract

Erythema multiforme (EM) is an acute inflammatory, mucocutaneous, psychosomatic, and vesiculobullous condition that varies from minor to major forms. The acral distribution of target lesions is a characteristic of this condition. The aetiology of erythema multiforme is multifactorial. 90% of the cases are triggered by a herpes infection, whereas 10% occur secondary to drug intake. The offending drugs include nonsteroidal anti-inflammatory drugs, antibiotics, and anticonvulsants. The present case series discusses four cases of drug-induced erythema multiforme and their management.

Publication types

Case Reports